StreetInsider.com News Articles

Form 144 KALA BIO, Inc. Filed by: Rosen Howard B

Thu, 12 Mar 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260312/26154749.html

Form 144 KALA BIO, Inc. Filed by: Rosen Howard B

Thu, 12 Mar 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260312/26154749.html

Form 144 KALA BIO, Inc. Filed by: Myers C. Daniel

Thu, 12 Mar 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260312/26152896.html

Form 144 KALA BIO, Inc. Filed by: Myers C. Daniel

Thu, 12 Mar 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260312/26152896.html

Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents

Wed, 11 Mar 2026 11:18:00 -0400

Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA)

Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Younet.ai, a Toronto-based AI technology company specializing in enterprise-grade private LLM solutions, today announced that the recent release of AutoResearch by AI pioneer Andrej Karpathy provides strong external validation for the autonomous research-agent approach underpinning Researgency.ai, Younet's agentic research platform being developed in collaboration with Kala Bio, Inc. (NASDAQ: KALA).

AutoResearch is an open-source tool that enables AI agents to autonomously conduct 100+ machine-learning experiments overnight on a single GPU,

Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents

Wed, 11 Mar 2026 11:18:00 -0400

Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA)

AutoResearch is an open-source tool that enables AI agents to autonomously conduct 100+ machine-learning experiments overnight on a single GPU,

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Wed, 11 Mar 2026 10:00:26 -0400

DENVER, March 11, 2026 (GLOBE NEWSWIRE) -- A fresh wave of developments across artificial intelligence, healthcare technology, and digital infrastructure is reinforcing a central theme dominating markets: the rapid convergence of AI with data-heavy industries. From biotech platforms deploying autonomous agents to data-center integrators scaling AI infrastructure, companies are positioning themselves to capture value from the next phase of the technology cycle.

Leading the narrative is KALA BIO (NASDAQ: KALA), which announced it expects to deploy its first commercial AI agent within approximately two weeks as part of the rebranded Researgency.ai platform. The company is attempting to

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Wed, 11 Mar 2026 10:00:26 -0400

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Wed, 11 Mar 2026 10:00:26 -0400

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Wed, 11 Mar 2026 10:00:26 -0400

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Wed, 11 Mar 2026 10:00:26 -0400

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

Wed, 11 Mar 2026 10:00:26 -0400

Kala Bio plans to ship first AI agent within 14 days

Wed, 11 Mar 2026 06:31:55 -0400

Kala Bio Inc. (NASDAQ: KALA) announced it expects to deliver its first commercial AI product within approximately 14 days, according to a company statement. The clinical-stage biopharmaceutical company said it has completed a rebrand of its Researgency.ai platform and is positioning itself to serve both biotechnology development and AI platform services.

The company said its scientists are working with Younet's AI engineering team to build the first custom AI agent. "The rebrand was important, but the real story is what happens next, we launch," said Avi Minkowitz, CEO of Kala Bio. "Our first agent ships in 14 days."

The Researgency.ai platform is

Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates

Wed, 11 Mar 2026 06:30:00 -0400